A study to assess the pharmacokinetics, and glucodynamics of LY3209590 in participants with type 2 diabetes

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508008-39-00

Acronym

I8H-MC-BDDG

Enrollment

Registered

2023-12-01

Start date

2023-12-05

Completion date

2024-07-18

Last updated

2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026